Xiaoyan Zhou

3.4k citations
120 papers · 2.5k indexed · h-index 29
Topics
Renin-Angiotensin System Studies (14 papers)Blood Pressure and Hypertension Studies (14 papers)Hormonal Regulation and Hypertension (9 papers)

In The Last Decade

Xiaoyan Zhou

113 papers receiving 2.5k citations

Peers

Xiaoyan Zhou
Comparison fields: 5 of 130
  • Molecular Biology 1.1k
  • Cancer Research 496
  • Cardiology and Cardiovascular Medicine 383
  • Endocrinology, Diabetes and Metabolism 322
  • Surgery 267
Replace Assunta Pandolfi with:
Assunta Pandolfi Italy
Teresa Villarreal‐Molina Mexico
Aijun Sun China
M. Yvonne Alexander United Kingdom
Zia A. Khan Canada
Danielle Kamato Australia
Jaana Rysä Finland
Sergiu‐Bogdan Catrina Sweden
Boris Vaisman United States
Xiaoyan Zhou relative to Assunta Pandolfi Italy Assunta Pandolfi's profile →
Citations per field
00.5×1.5×
Assunta Pandolfi · 1×
Citations per year

Countries citing papers authored by Xiaoyan Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Zhou more than expected).

Fields of papers citing papers by Xiaoyan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Zhou. The network helps show where Xiaoyan Zhou may publish in the future.

Co-authorship network of co-authors of Xiaoyan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Zhou. A scholar is included among the top collaborators of Xiaoyan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Zhou. Xiaoyan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 5
6 3
7 1
8 1
9 8
10 28
11 19
12 31
13 36
14 5
15 1
16 32
17 10
18 2
19 9
20 4

About Xiaoyan Zhou

Xiaoyan Zhou is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Clinical Biochemistry, having authored 120 papers that have together received 2.5k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (14 papers), Blood Pressure and Hypertension Studies (14 papers) and Hormonal Regulation and Hypertension (9 papers). The work is most often cited by research in Cancer Research (496 citations), Nephrology (158 citations) and Endocrinology, Diabetes and Metabolism (322 citations). Xiaoyan Zhou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Edward D. Fröhlich, Hidehiko Ono, Dong Ma, Hua Hao, Wei Xue, Dinko Sušić, Luis C. Matavelli, Yuko Ono, Yonghong Huang and Jiake Xu. Their work appears in journals such as PLoS ONE, Scientific Reports and Cochrane Database of Systematic Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026